FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On December 2, 2005
Table of Contents
Docket # Title
1976N-0052G OTC general comments & combinations
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
2001D-0044 Clinical Laboratory Improvement Amendments of 1988
2002N-0273 Animal Proteins Prohibited in Ruminant Feed
2004G-0381 Records Access Authority Provided in Title III, Subtitle A, of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002
2005D-0438 Guidance for Industry on Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency
2005N-0335 Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Device Recall Authority -- 21 CFR Part 810
2005N-0446 Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients
1976N-0052G OTC general comments & combinations
C 232 BDI MArketing, Inc. (BDI) Vol #: 35
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
C 7512 Form Letters Vol #: 333
2001D-0044 Clinical Laboratory Improvement Amendments of 1988
C 41 F. Lehr, MS, MT(ASCP) Vol #: 3
2002N-0273 Animal Proteins Prohibited in Ruminant Feed
C 302 American Proteins, Inc. Vol #: 28
C 303 Eligible Vol #: 28
C 304 Eligible Vol #: 28
C 305 K. Flagg Vol #: 28
C 306 N. Osterhout Vol #: 28
C 307 M. Ross Vol #: 28
C 308 F. Charles Vol #: 28
C 309 J. Stewart Vol #: 28
C 310 M. Renckert Vol #: 28
C 311 D. Howe Vol #: 28
C 312 R. Fedele Vol #: 28
C 313 R. Corey Vol #: 28
C 314 J. Scheib Vol #: 28
C 315 J. Sprague Vol #: 28
C 316 T. Webster Vol #: 28
C 317 W. Givens Vol #: 28
C 318 H. Cleaver Vol #: 28
C 319 A. Glick Vol #: 28
C 320 Eligible Vol #: 28
2004G-0381 Records Access Authority Provided in Title III, Subtitle A, of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002
GDL 2 Guideline Vol #: 1
NAD 2 FDA Vol #: 1
2005D-0438 Guidance for Industry on Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency
GDL 1 Guideline Vol #: 1
NAD 1 FDA Vol #: 1
2005N-0335 Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Device Recall Authority -- 21 CFR Part 810
N 2 FDA Vol #: 1
2005N-0446 Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients
BKG 1 Background Vol #: 1
NRD 1 FDA Vol #: 1

Page created on December 13, 2005 RSC

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management